Shares of health-care companies rose as a lower dollar promised to buoy revenue for Big Pharma.
Continue Reading Below
Companies such as Merck, Pfizer and Eli Lilly export billions of dollars of drugs world-wide, and more than a half decade of dollar appreciation has eaten into their revenue tallies.
Shares of the Advisory Board Co. rose after the software and consulting firm said it would be split in two and sold, with its health-care unit being taken over by UnitedHealth Group and its education unit going to leveraged-buyout firm Vista Equity Partners.
Rob Curran, email@example.com
(END) Dow Jones Newswires
August 29, 2017 16:30 ET (20:30 GMT)